The Pentagon issued new guidance on September 17, 2026, mandating testosterone deficiency screening for male active-duty and reserve service members aged 30 and older. This decision follows the temporary rescission of previous guidance earlier in the month. The updated directive aims to address male testosterone deficiency and create standardized screening and treatment protocols across the Defense Health Agency.
✓ AI-Debiased Article
4
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
Pentagon issues updated guidance on testosterone testing for service members
The Pentagon has released new guidance requiring testosterone deficiency screenings for male service members over 30 years old. This update comes after the previous guidance was temporarily rescinded earlier in September 2026.
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
Pentagon issues new guidance for testosterone testing after rescinding previous one
Neutral Headline
Pentagon issues updated guidance on testosterone testing for service members